Concepedia

Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington, G. A. Hitman, H. A. W. Neil, Shona Livingstone, Valentine Charlton-Menys, David A. DeMicco, John Fuller

American Journal of Kidney Diseases · 2009 · 254 citations · 18 references

DOI

Concepts

References

18

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text

, , +10

National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

Andrew S. Levey, Josef Coresh, Ethan M. Balk et al. · Annals of Internal Medicine · 2003 · 4.6K citations

, , +17

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington et al. · The Lancet · 2004 · 3.8K citations

, , +9

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · Obstetrical & Gynecological Survey · 2009 · 3.7K citations

, , +10

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

The Lancet · 2005 · 3.3K citations

, , +13